Scribe Therapeutics, Inc. (SCTX)
Nasdaq · Biological Products, (No Diagnostic Substances) · Inc. DE
What they're doing
Between 2026-06-21 and 2026-09-19, public records show 7 signals for Scribe Therapeutics, Inc.. Most notable: 2026-07-24: Aghazadeh Behzad; Avoro Capital Advisors LLC; Avoro Ventures LLC (director) bought $35.0M of stock; 2026-07-27: 4 insiders bought $71.1M within 14 days; 2026-07-27: GORDON CARL L (director) bought $15.0M of stock. Federal contract obligations over the last 24 months total $0. This summary was assembled automatically from SEC EDGAR, USAspending.gov, U.S. Senate lobbying disclosures and Wikimedia pageview counts.
Generated 2026-09-19 from public records.
Signals, last 12 months
- Insider purchaseAghazadeh Behzad; Avoro Capital Advisors LLC; Avoro Ventures LLC (director) bought $144k of stock
- Insider buying cluster4 insiders bought $71.1M within 14 days
- Insider purchaseGORDON CARL L (director) bought $15.0M of stock
- Insider purchaseORBIMED ADVISORS LLC; OrbiMed Capital GP VIII LLC (director) bought $15.0M of stock
- Insider purchaseAH Bio Fund II, L.P.; AH Equity Partners Bio II, L.L.C.; AH Bio Fund III, L.P.; AH Equity Partners Bio III, L.L.C.; Andreessen Marc L; HOROWITZ BENJAMIN A (ten_percent_owner) bought $5.0M of stock
- Insider purchaseAghazadeh Behzad; Avoro Capital Advisors LLC; Avoro Ventures LLC (director) bought $35.0M of stock
- Insider purchaseAghazadeh Behzad; Avoro Capital Advisors LLC; Avoro Ventures LLC (director) bought $1.1M of stock
Insider transactions
| Date | Insider | Role | Code | Shares | Price | Value |
|---|---|---|---|---|---|---|
| 2026-07-28 | Aghazadeh Behzad; Avoro Capital Advisors LLC; Avoro Ventures LLC | director | P | 7,905 | 18.25 | $144,266 |
| 2026-07-27 | AH Bio Fund II, L.P.; AH Equity Partners Bio II, L.L.C.; AH Bio Fund III, L.P.; AH Equity Partners Bio III, L.L.C.; Andreessen Marc L; HOROWITZ BENJAMIN A | ten percent owner | C | 2,051,742 | — | — |
| 2026-07-27 | AH Bio Fund II, L.P.; AH Equity Partners Bio II, L.L.C.; AH Bio Fund III, L.P.; AH Equity Partners Bio III, L.L.C.; Andreessen Marc L; HOROWITZ BENJAMIN A | ten percent owner | C | 697,650 | — | — |
| 2026-07-27 | AH Bio Fund II, L.P.; AH Equity Partners Bio II, L.L.C.; AH Bio Fund III, L.P.; AH Equity Partners Bio III, L.L.C.; Andreessen Marc L; HOROWITZ BENJAMIN A | ten percent owner | P | 333,333 | 15 | $4,999,995 |
| 2026-07-27 | GORDON CARL L | director | C | 348,825 | — | — |
| 2026-07-27 | GORDON CARL L | director | P | 1,000,000 | 15 | $15,000,000 |
| 2026-07-27 | ORBIMED ADVISORS LLC; OrbiMed Capital GP VIII LLC | director | C | 348,825 | — | — |
| 2026-07-27 | ORBIMED ADVISORS LLC; OrbiMed Capital GP VIII LLC | director | P | 1,000,000 | 15 | $15,000,000 |
| 2026-07-27 | Doudna Jennifer A | ten percent owner | C | 12,511 | — | — |
| 2026-07-24 | Aghazadeh Behzad; Avoro Capital Advisors LLC; Avoro Ventures LLC | director | P | 2,333,333 | 15 | $34,999,995 |
| 2026-07-24 | Aghazadeh Behzad; Avoro Capital Advisors LLC; Avoro Ventures LLC | director | P | 50,000 | 22.31 | $1,115,500 |
| 2026-07-23 | Lucas Svetlana | officer | P | 3,000 | 15 | $45,000 |
| 2026-07-23 | Parrot David | officer | P | 1,333 | 15 | $19,995 |
| 2026-07-23 | Parrot David | officer | P | 1,333 | 15 | $19,995 |
Federal contracts
No federal contract actions on record for this recipient mapping.
Lobbying
No federal lobbying filings on record for this client mapping.
Public attention
No Wikipedia pageview data linked to this company.
Recent filings
- 2026-09-02 10-Q
- 2026-09-02 8-K
- 2026-08-03 SCHEDULE 13G
- 2026-07-30 SCHEDULE 13D
- 2026-07-30 SCHEDULE 13D
- 2026-07-29 4
- 2026-07-29 4
- 2026-07-29 4
- 2026-07-29 SCHEDULE 13D
- 2026-07-29 4
- 2026-07-28 4
- 2026-07-28 4
- 2026-07-27 4
- 2026-07-27 4
- 2026-07-27 4
- 2026-07-27 4
- 2026-07-27 4
- 2026-07-27 4
- 2026-07-27 4
- 2026-07-27 8-K